C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/19 (2006.01) A61K 38/19 (2006.01) C07K 14/52 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2207036
Modifications to RANTES can result in the modified polypeptide acting as a RANTES or MIP-1.alpha. antagonist. Such antagonists can be used in therapy to reduce inflammation. They are also useful in studying the properties of RANTES or of MIP-1.alpha..
Des modifications de la protéine RANTES peuvent résulter en un polypeptide modifié agissant comme un antagoniste de RANTES ou de MIP-1.alpha.. On peut utiliser de tels antagonistes en thérapie afin de réduire l'inflammation. Ces antagonistes sont également utiles dans l'étude des propriétés de RANTES ou de MIP-1.alpha..
Proudfoot Amanda Elizabeth Innes
Wells Timothy Nigel Carl
Glaxo Group Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Rantes peptide and fragments and compositions comprising it... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rantes peptide and fragments and compositions comprising it..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rantes peptide and fragments and compositions comprising it... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771711